Series A Life Science Companies

Capacity Bio is a therapeutics company that is focused on mitophagy.

Watershed Informatics catalyzes discovery by democratizing access to bioinformatics tools for biologists.

Teitur Trophics is a biotech company developing novel treatments for neurodegenerative diseases.

Flightpath Biosciences is a biotechnology company that develops medications to treat rare infectious diseases.

Mantra Bio is the creator of REVEAL, an exosome engineering platform combining computational biology and lab automation.

Horama develops gene therapies for rare inherited ocular and CNS (central nervous system) diseases.

LinKinVax operates as a clinical-stage biotechnology company.

Engitix is operates as a tissue engineering company.

Prudentia Sciences is a platform enables AI-powered Asset Diligence and Valuation to De-Risk Investment in Drug Development.

Moonwalk Biosciences operates a genomic medicine company that aims to provide a new class of precision epigenetic medications.

Gandeeva’s proprietary platform provides a rational, cryo-EM- and AI-driven approach for the design of potent molecular glues.

Pranax is a biotechnology company that develops and commercializes regenerative medicine solutions centered on exosome technology.

Developer of a pharmaceutical platform and drugs created for the treatment of the central nervous system.

XFOREST Therapeutics is a biotech company focused on drug discovery using RNA structures.

PreComb develops technologies to optimally adapt the therapies to each patient for difficult-to-treat cancers.

Antag Therapeutics provides therapeutic peptides for the treatment of dietary-related metabolic diseases.

Excelsior Sciences applies AI and automated chemistry to simplify small-molecule discovery and accelerate overall drug development.

Neutrolis is a candidate-stage company advancing its first-in-class therapies that target Neutrophil Extracellular Traps (NETs).

Digital Biotechnologies is a biotechnology company.

Revolutionizing Atrial Fibrillation Treatment with Groundbreaking Technology

REM People is a new-generation retail analytics company that provides AI-powered omni-channel sales efficiency solutions.

RheumaGen develops a class of cell and gene therapy treatments aimed at autoimmune diseases.

Gennao Bio is a genetic medicines company that develops targeted nucleic acid therapeutics to cure muscle diseases.

Superfluid Dx is a biotechnology company developing novel blood-based early detection.

FoRx Therapeutics is a biotechnology company developing a new generation of cancer drugs focusing on novel DNA Replication Stress pathways.